CEO Total Pay
$1.6M
FY2021 Summary Compensation, below median
ARCT FY2021 SEC EDGAR DEF 14A
Arcturus Therapeutics Holdings Inc. CEO pay ratio
The CEO earned $1.6M in FY2021 against median worker pay of $406,110 · Chemicals & Pharmaceuticals.
- State
- DE
- Filing date
- 2022-05-02
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2021
Data updated August 2026
Subscribe to Arcturus Therapeutics Holdings Inc. CEO pay filing updates (RSS)
CEO-to-worker pay ratio
4:1
Below Average (Scale: 0–1000:1)
CEO pay
$1.6M
Median worker
$406,110
Latest filing FY2021. This company's newest DEF 14A on file is for FY2021, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Arcturus Therapeutics Holdings Inc. reported a 4:1 CEO-to-worker pay ratio in FY2021 - at or below the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 4:1
- FY2021 disclosed
- CEO total
- $1.6M
- Summary Compensation Table total
- Median worker
- $406,110
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2021
A component-level pay breakdown is not reported in Arcturus Therapeutics Holdings Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
4:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$1.6M
Companies in Industry
168
vs. Industry Median
Below
Arcturus Therapeutics Holdings Inc.: near-parity Item 402(u) ratio
Arcturus Therapeutics Holdings Inc. stamps FLOOR · ELITE-MED at 4:1 against $406,110 median worker pay in FY2021. the CEO earned 4× the median employee ($406,110) in FY2021.
At $406,110 median worker pay, the FLOOR stamp is near pay-parity territory under LIGHT CEO total.
Pay Ratio
4:1
Below typical
What FY2021 shows for Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. stamps FLOOR · ELITE-MED at 4:1 against $406,110 median worker pay in FY2021. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Arcturus Therapeutics Holdings Inc.'s $1.6M CEO total is at or below the $7.9M industry median CEO pay.
Arcturus Therapeutics Holdings Inc. stamps FLOOR · LIGHT · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2021
- Total Compensation
- $1.6M
- Median Employee Pay
- $406,110
- Pay Ratio
- 4:1
- Filing Date
- 2022-05-02
Company Info
- Ticker
- ARCT
- CIK
- 1768224
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2834
- State
- DE
SEC EDGAR DEF 14A for CIK 1768224, FY2021. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Arcturus Therapeutics Holdings Inc. stamps FLOOR · ELITE-MED at 4:1 against $406,110 median worker pay in FY2021.
Read with Arcturus Therapeutics Holdings Inc.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · LIGHT · ELITE-MED.
Siga Technologies Inc · LIGHT
ABS(ceo_total_comp) peer at $1.6M (Δ $408 lighter vs Arcturus Therapeutics Holdings Inc.); FLOOR · ELITE-MED vs this page's FLOOR · LIGHT · ELITE-MED.
UNIVEST FINANCIAL Corp · LIGHT
ABS(ceo_total_comp) peer at $1.6M (Δ $1K lighter vs Arcturus Therapeutics Holdings Inc.); FLOOR · HIGH-MED vs this page's FLOOR · LIGHT · ELITE-MED.
New Relic, Inc. · LIGHT
ABS(ceo_total_comp) peer at $1.6M (Δ $5K heavier vs Arcturus Therapeutics Holdings Inc.); FLOOR · ELITE-MED vs this page's FLOOR · LIGHT · ELITE-MED.
Primis Financial Corp. · LIGHT
ABS(ceo_total_comp) peer at $1.6M (Δ $7K lighter vs Arcturus Therapeutics Holdings Inc.); MODEST · PAR-MED vs this page's FLOOR · LIGHT · ELITE-MED.
Chemicals & Pharmaceuticals benchmark
Arcturus Therapeutics Holdings Inc. stamps FLOOR · LIGHT · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · FLOOR
See where FLOOR · LIGHT packages sit on the national leaderboard after reading Arcturus Therapeutics Holdings Inc..
Ratio primer · FLOOR
Arcturus Therapeutics Holdings Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Arcturus Therapeutics Holdings Inc. (CIK 1768224), FY2021. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.